TScan Therapeutics, Inc. - 10-Q Filing

TScan Therapeutics reports outstanding share count of 63.5 million voting and 4.28 million non-voting common shares as of November 5, 2026.

SEC EDGAR ·

Tickers: $TCRX

Read the full article at SEC EDGAR

More Regulatory news